维普期刊资源整合服务平台（V6.5）

24篇 您的检索式：作者名="Cavalloni"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Antitumor activity of Src inhibitor saracatinib (AZD-0530) in preclinical models of biliary tract carcinomas显示文摘	Cavalloni G Peraldo-Neia C Sarotto I	2012	Mol Cancer Ther2012，11，7：	1
2	Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression显示文摘	Perissinotto E Cavalloni G Leone F		0，，2：	1
3	HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib 显示文摘	Valabrega G Capellero S Cavalloni G	2011	Breast Cancer Res Treat2011，130，1：	1
4	Biliary tract carcinomas: From chemotherapy to targeted therapy显示文摘	Donatella Marino Francesco Leone Giuliana Cavalloni Celeste Cagnazzo Massimo Aglietta	2012	Critical Reviews in Oncology / Hematology2012，，：	1
5	Sorafenib blocks tumour growth,angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2,MCL-1 and ezrin pathways显示文摘	Pignochino Y Grignani G Cavalloni G	2009	Mol Cancer2009，8，1：	1
6	Somatic mutations of epi- dermal growth factor receptor in bile duct and gallbladder carcino- ma显示文摘	Leone F Cavalloni G Pignochino Y	2006	Clin Cancer Res2006，12，6：	1
7	Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression 显示文摘	Perissinotto E Cavalloni G Leone F	2005	Clin Cancer Res2005，11，：	1
8	In- volvement of chemokine receptor 4/stromal cell- derived factor 1 system during osteosarcoma tumor progression 显示文摘	Perissinotto E Cavalloni G Leone F	2005	Clin Cancer Res2005，11，21：	1
9	Somatic Mutations of Epidermal Growth Factor Receptor in Bile Duct and Gallbladder Carcinoma 显示文摘	Leone F Cavalloni G Pignochino Y	2006	Clin Cancer Res2006，12，6：	1
10	Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression显示文摘	Perissinotto E Cavalloni G Leone F	2005	Clin Cancer Res2005，11，2：	1
11	Biliary tract carcinomas: From chemotherapy to targeted therapy显示文摘	Marino D Leone F Cavalloni G	2013	Crit Rev Oncol Hema- tol2013，85，2：	1
12	Biliary tract carcinomas:from chemotherapy to targeted therapy显示文摘	Marino D Leone F Cavalloni G	2013	Crit Rev Oncol Hematol2013，85，2：	1
13	Sorafenib blocks tumourgrowth, angiogenesis and metastatic potential in preclinical models of os-teosarcoma through a mechanism potentially involving the inhibition ofERK1/2,MCL-1 and ezrin pathways显示文摘	Pignochino Y Grignani G Cavalloni G	2009	Mol Cancer2009，8，：	1
14	Somatic mutations of epidermal growth factor receptor in bile duct and gallbladder carcinoma显示文摘	Leone F Cavalloni G Pignochino Y	2006	Clin Canner Res2006，12，6：	1
15	Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression显示文摘	Perissinotto E Cavalloni G Leone F	2005	Clin Cancer Res2005，11，2：	1
16	Sorafenib blocks tumour growth, angiogenesis and metastatic poten- tial in preelinical models of cervical cancer through a mechanism potentially involving the inhibition of ERK1/2, MCL-I and ezrin pathways 显示文摘	Pignochino Y Griguani G Cavalloni G	2009	Mol Cancer2009，8，：	1
17	Sorafenib blocks tumour growdi,angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2,MCL-and ezrin pathways显示文摘	Pignochino Y Grignani G Cavalloni G	2009	Mol Cancer2009，8，：	1
18	Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression 显示文摘	Perissinotto E Cavalloni G Leone F	2005	Clin Cancer Res2005，11，21：	1
19	Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression显示文摘	Perissinotto E Cavalloni G Leone F		0，，2：	1
20	Involvement of chemokine receptor 4/stromal cell -derived factor 1 system during osteosarcoma tumor progression 显示文摘	Perissinotto E Cavalloni G Leone F	2005	Clin Cancer Res2005，11，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示